Optivar

Optivar is a brand name of azelastine ophthalmic, approved by the FDA in the following formulation(s):

OPTIVAR (azelastine hydrochloride - solution/drops; ophthalmic)

• 
  Manufacturer: MEDA PHARMS
  
  Approval date: May 22, 2000
  
  Strength(s): 0.05% ^[RLD][AT]

Has a generic version of Optivar been approved?

Yes. The following products are equivalent to Optivar:

azelastine hydrochloride solution/drops; ophthalmic

• 
  Manufacturer: APOTEX INC
  
  Approval date: August 3, 2009
  
  Strength(s): 0.05% ^[AT]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: June 21, 2010
  
  Strength(s): 0.05% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Optivar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Optivar.

See also...

• Optivar Drops Consumer Information (Wolters Kluwer)
• Optivar Consumer Information (Cerner Multum)
• Optivar Advanced Consumer Information (Micromedex)
• Azelastine Drops Consumer Information (Wolters Kluwer)
• Azelastine ophthalmic Consumer Information (Cerner Multum)
• Azelastine Ophthalmic Advanced Consumer Information (Micromedex)
• Azelastine Hydrochloride AHFS DI Monographs (ASHP)